Skip to content

Clinical trials

Liver Cirrhosis trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Country / region: Singapore Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20182
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changi General Hospital2
Sanofi2
AstraZeneca1
Boehringer Ingelheim1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Stem Med Pte. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis10
Fibrosis3
Ascites2
Non-alcoholic Fatty Liver Disease2
Carcinoma, Hepatocellular1
Fatty Liver1
Frailty1
Hepatitis1
Metabolic Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.